NASDAQ
INmune Bio, Inc. (INMB) has a fcf yield of -56.96% as of Friday, May 29, 2026. This represents a 158.52% decrease compared to its 12-month average of -22.03%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.